🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Some professionals stated the popularity for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Removal

According to the social media company, the service has taken down problematic content and banned related hashtags and query recommendations. The company stated it was committed to maintaining the service secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, filled with images of weight loss, positive reviews and step-by-step guides for mixing or injecting at home.

Within moments of entering one group, a vendor shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.

Item Details and Pricing

Inside these communities, posts display black plastic packages with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially serious health risks”.